New type of fully synthetic tetracycline antibiotic: eravacyclineSHI Yu-xing, ZHAO Ye, LIU Xiang-kui121-124
Key points of clinical trial design of anti-rabies virus monoclonal antibodiesLIN Lin, ZHAO Jian-zhong, LIU Li-hua, WEI Chun-min, ZENG Xin125-128
Preparation and pharmacokinetic study of ibuprofen rapid-release and sustained-release bilayer tabletsJIA Lu-yao, ZHAO Shi-juan, SHI Yun-long, JIANG Xiao-hong, YANG Lei, YIN Li-fang129-135
Thoughts on selection of new drug development mode in ChinaAO Yi, PU Run, LU Shan, SUN Yan-rong136-142
Progress in study of drug-induced cholestasis liver injuryWU Wen-xiao, WANG Ting, GENG Xing-chao, LI Bo143-151
Progress in research on the effect of sodium-glucose co-transporter 2 inhibitors on cardiovascular system in diabetic patientsTAN Xiang-shan, JI Li-wei, ZHANG Xian152-157
The application of brain partition steady state hypothesis and extracellular space administration in development of new drugs for central nervous system diseasesGAO Ze-yu, ZHAO Xin, LIN Ming, PU Xiao-ping, HAN Hong-bin158-164
Advances in development of new drugs for treating Duchenne muscular dystrophyBU Xin-jue, XI Xin, LIU Song-qing, DU Qian165-169
Research progress of ferritin nanocageJI Peng, WANG Si-qi, CHEN Yi-wei, WANG Le, QI Xiao-le, WU Zheng-hong170-175
Determination of captopril in human plasma for bioequivalence study by liquid chromatography-tandem mass spectrometry with pre-column derivatizationCHEN Tao, ZHONG Kan, XUE Cai-fu, YANG Bei, CHEN Xiao-yan, ZHONG Da-fang, ZHU Xiao-tong, YANG Yong176-182